Lactose
In clinical developmentAlso known as LACTOSE, UNSPECIFIED FORM, Milk sugar, Saccharum Lactis.
Recent clinical, regulatory, research and industry developments relating to this drug.
A Prospective Study to Evaluate the Effect of Allopurinol on Muscle Energetics in Primary Sarcopenia
Comparing the Efficacy of Pregabalin and Hydroxyzine on the Anxiety Score
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
A Prospective Study to Evaluate the Effect of Allopurinol on Muscle Energetics in Primary Sarcopenia
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes4
Journals, researchers & institutions
- Nature communications1
- Ambalavanan A1
- Anand SS1
- Azad MB1
- Bode L1
- Chang L1
- Choi J1
- Duan Q1
- Fang ZY1
- Chanchlani Research Centre1
- Complutense University of Madrid1
- Department of Pediatrics and Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence (MOMI CORE)1
- Egerton University1
- Hawassa University1
- Hospital for Sick Children and University of Toronto1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across the same disease area as Lactose in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials